MPR Weekly Dose
Episodes
MPR Weekly Dose 74 - Updated travel guidance; Six month vaccine efficacy data; Increased Moderna doses per vial; New ADHD treatment; And a safety communication for lamotrigine
09 Apr 2021
Contributed by Lukas
Back to regular programming this week with a summary of the top news, which includes updated travel guidance; Six month efficacy data for the Moderna ...
MPR Weekly Dose #73: Interview with Dr Joshua Barocas
30 Mar 2021
Contributed by Lukas
With three FDA authorized vaccines being administered throughout the US, but new variants growing in number, we are at a crucial moment in the COVID-...
MPR Weekly Dose 72 - Real world vaccine effectiveness; Two-dose completion data; Moderana pediatric trial; Results from tocilizumab plus remdesivir trial; Kimyrsa approved.
18 Mar 2021
Contributed by Lukas
This week we have new study data on the real-world effectiveness of the Pfizer-BioNTech vaccine; The number of Americans who are completing both vacci...
MPR Weekly Dose 71 - Guidance for those fully vaccinated; A first in COVID-19 testing; Povidone Iodine and Bamlanivimab-Etesevimab examined; Delayed local vaccine reactions
12 Mar 2021
Contributed by Lukas
This week it's all COVID related news; There's new CDC guidance for those who are vaccinated; A first over the counter test that doesn't require a pre...
MPR Weekly Dose 70 - Keytruda indication withdrawn; Janssen's single-shot vaccine gains EUA; Ivermectin assessed for mild COVID-19; FDA clears wearables
05 Mar 2021
Contributed by Lukas
This week we have news of an indication for the cancer treatment, Keytruda, being withdrawn; Janssen's single dose vaccine gains Emergency Authorizati...
MPR Weekly Dose #69 - False and misleading pharma promo; Novel LDL-C therapy; Heart failure Tx expanded; Migraine device okay'd for teens.
18 Feb 2021
Contributed by Lukas
An FDA warning over pharma company's promo material; Entresto's approval is expanded, There's approvals in homozygous familial hypercholesterolemia an...
MPR Weekly Dose #68 - Remdesivir compounding; Emergency Use Authorizations; Sleep apnea device; New Botox approval
12 Feb 2021
Contributed by Lukas
This week's stories include a caution about remdesivir; New and updated Emergency Use Authorizations; And new approvals in sleep apnea and for Botox.
MPR Weekly Dose #67 - Efficacy data for AstraZeneca, J&J and Novovax vaccines; Approvals in analgesia and influenza.
05 Feb 2021
Contributed by Lukas
This week we take a look at the remaining prospective COVID vaccines, that includes AstraZeneca, J&J and Novovax; There's also drug approvals for anal...
MPR Weekly Dose 66 - The Moderna vaccine's efficacy against new variants; Merck ends development of new vaccines; Antiviral treatment combos show promise; New lupus nephritis treatment
28 Jan 2021
Contributed by Lukas
On this week's pod: The Moderna vaccine and what we know about its effectiveness against emerging variants; Merck ends it's development of two vaccine...
MPR Weekly Dose #65 - Johnson & Johnson's vaccine candidate; Blood donations during pandemic; New Tx for heart failure with reduced ejection fraction; A potential Alzheimer drug; Changes to vinca alkaloid labeling
22 Jan 2021
Contributed by Lukas
On this week's MPR pod we take a look at the current status of Johnson & Johnson's COVID-19 vaccine candidate; Considerations in assessing blood donor...
MPR Weekly Dose #64 - Pfizer-BioNTech vaccine efficacy against new variant; Ravulizumab trial halted; Rapid concussion test; Novel chronic kidney disease Tx; NSAID recalled
15 Jan 2021
Contributed by Lukas
This week we have news of the neutralizing response of the Pfizer-BioNTech vaccine to the new COVID-19 variant; A trial investigated ravulizumab in ad...
MPR weekly dose #63 - COVID-19 vaccine admin scheduling and production updates; A diagnostic test that is giving false negative results; Bristol Myers Squibb withdraws an indication for Opdivo; And experts vote on the best diets for 2021.
08 Jan 2021
Contributed by Lukas
On the first MPR pod of 2021 we cover the latest COVID-19 news including admin. scheduling and production news; A diagnostics test that is giving fals...
MPR Weekly Dose #62 - Major vaccine developments; FDA authorizes rapid at-home COVID test; New findings for glucosamine supplementation; And a novel budesonide oral suspension gets Priority Review
18 Dec 2020
Contributed by Lukas
Its been a long year, but the monumental efforts to achieve a COVID-19 vaccine are bearing some fruits, we about that, and also a fully at home diagno...
MPR Weekly Dose #61 - Sitagliptin findings in pediatrics; Obesity treatment gains expanded approval; The FDA issue a CRL; And a new transdermal contraceptive
11 Dec 2020
Contributed by Lukas
This week we cover new findings for the diabetes drug sitagliptin in pediatrics; An obesity treatment has approval expanded; The FDA issue a Complete ...
MPR Weekly Dose #60 - The FDA stand by remdesivir; Who should get the vaccine first? Xolair and Hetlioz gain expanded approvals; And a novel neuroblastoma treatment
04 Dec 2020
Contributed by Lukas
This week we cover a back and forth between the FDA and the WHO over remdesivir efficacy; Recommendations for who should get a COVID vaccine first; Xo...
MPR Weekly Dose #59 - The latest on vaccine news from Moderna, and BioNTech and Pfizer as they release more trial data; A at-home diagnostic test; Keytruda gains expanded approval; and more
20 Nov 2020
Contributed by Lukas
The latest on vaccine news from Moderna, and BioNTech and Pfizer as they release more trial data; A at-home diagnostic test is approved; Keytruda gain...
MPR Weekly Dose #58 - Major developments in COVID vaccine and antibody treatments; Also an FDA Advisory Committee vote on what would be the first Alzheimer drug in decades.
13 Nov 2020
Contributed by Lukas
Major developments in COVID-19 vaccine and antibody treatments: Are we close to having a vaccine gain Emergency Use Authorization? The antibody bamlan...
MPR Weekly Dose #57 - NDA in diabetes; Post-op implant pain Tx; DEA schedules new opioid; FDA lists 200+ drugs; Rifaximin and other drugs in the pipeline news
06 Nov 2020
Contributed by Lukas
This week we cover a new treatment submission to the FDA for the prevention of diabetes; The launch of a bupivacaine implant to treat post op pain; Th...
MPR Weekly Dose Episode #56 - Antibody responses; Convalescent plasma; Nasal spray for diabetic gastroparesis; Colorectal cancer screening recommendations; New dry eye treatment; And movie trivia!
30 Oct 2020
Contributed by Lukas
This week: The study that identified factors associated with strong antibody responses to COVID; How convalescent plasmas benefits may be limited; A n...
MPR Weekly Dose Podcast Episode 55
23 Oct 2020
Contributed by Lukas
This week on the pod: Results from the survey assessing willingness to receive a COVID vaccine; Dr. Fauci shares that he is 'cautiously optimistic' a ...
Weekly Dose #54 - Vaccine trial halted; Hyperimmune trial begins; IV tramadol rejected; FDA votes on schizophrenia, bipolar Tx; And a first in Ebola treatment
16 Oct 2020
Contributed by Lukas
This week: News of another vaccine trial being put on hold; A trial assessing hyperimmue globulin beings; An NDA for IV tramadol is rejected; FDA Comm...
Weekly Dose #53 - Encouraging news on antibody therapies; EUA guidelines for potential vaccines; Remdesivir distribution; The HIV drug that failed to have an impact; And the preterm birth treatment the FDA want withdrawn from the market.
09 Oct 2020
Contributed by Lukas
This week on the pod; the latest COVID news, including encouraging news on antibody therapies; Updated on Emergency Use Authorization guidelines for v...
Weekly Dose #52 – New Moderna vaccine results; Boxed Warning for benzodiazepines; Point-of-care COVID-19 antibody test; Diphenhydramine overdoses linked to TikTok 'Challenge'; And FDA grants Nucala new approval.
02 Oct 2020
Contributed by Lukas
New Moderna vaccine results; Boxed Warning for benzodiazepines; Point-of-care COVID-19 antibody test; Diphenhydramine overdoses linked to TikTok 'Chal...
MPR Weekly Dose Podcast Episode 51
18 Sep 2020
Contributed by Lukas
This week we cover AstraZeneca and the swift decision to restart their COVID-19 vaccine candidate trial; Pfizer and BioNTech want to expand enrollment...
Weekly Dose #50 - Pause on vaccine trial; Benefits for steroid therapy in COVID patients; Higher doses of diabetes treatment okay'd; First non-hormonal contraceptive; FDA issue SCS warning
11 Sep 2020
Contributed by Lukas
We cover AstraZeneca's decision to pause their COVID-19 vaccine trial; New studies indicate benefits for steroid therapy in COVID patients; Higher dos...
Weekly Dose #49 - ACIP vaccine guidelines; Convalescent plasma; 15 minute test; Plant warning; Intrauterine device; Hydrochlorothiazide
28 Aug 2020
Contributed by Lukas
The ACIP release guidelines for the 2020-2021 vaccination recommendations; In COVID, there's developments in convalescent plasma authorization; A 15 m...
Pneumonia Associated COVID-19; Inaccurate Tests; Neck Gaiters; Drug Applications Halted; Narcan Update
21 Aug 2020
Contributed by Lukas
Treatment shows promise for patients who had pneumonia associated with COVID-19; A COVID-19 test that may have given inaccurate results; Neck gaiters ...
Weekly Dose #47: Remdesiver news; New opioid, SMA treatments; Sublingual epinephrine; Alzheimer treatment
14 Aug 2020
Contributed by Lukas
Remdesivir is submitted; New opioid approved by FDA; A new Spinal Muscular Atrophy treatment; A sublingual epinephrine treatment; and the latest on ...
COVID Vaccine Developments; Long-Term Facility Study; Cannabidiol; New Depression Treatment; Peanut Allergy Rejection
07 Aug 2020
Contributed by Lukas
This week there's more COVID vaccine developments; A first-of-its-kind trial assessing a drug for preventing COVID in long term care facilities; A can...
MPR Weekly Dose Podcast Episode 45
31 Jul 2020
Contributed by Lukas
It's been an important week with big developments in potential COVID-19 vaccines; News on how steroid therapy may help some COVID patients; There's re...
MPR Weekly Dose Podcast Episode 44
24 Jul 2020
Contributed by Lukas
This week: The government makes a $1.95 billion deal for a COVID-19 vaccine; Promising data from the Oxford vaccine trial; The CDC retakes control of ...
MPR Weekly Dose Podcast Episode 43
17 Jul 2020
Contributed by Lukas
This week; Significant moves in COVID-19 vaccine development; Research finds a link between PPI use and increased risk of COVID-19; We look at remdesi...
MPR Weekly Dose Podcast Episode 42
09 Jul 2020
Contributed by Lukas
The discontinuation of a trial investigating a potential COVID-19 treatment; A safety alert for toxic hand sanitizers; Vaccine guidance in the time of...
MPR Weekly Dose Podcast Episode 41
02 Jul 2020
Contributed by Lukas
This week on the Pod: The FDA issues guidance for COVID-19 vaccine development; Accuracy in COVID-19 antibody testing; How statins may improve outcome...
MPR Weekly Dose Podcast Episode 40
26 Jun 2020
Contributed by Lukas
This week on the Pod: Over-the-counter med recalls; a nasal spray approved for diabetic gastroparesis; reports of an uptick in penicillin-, ciprofloxa...
MPR Weekly Dose Podcast Episode 39
19 Jun 2020
Contributed by Lukas
This week we cover the latest in the rapidly shifting perception of chloroquine and hydroxychloroquine; The polio vaccine as a potential protector aga...
MPR Weekly Dose Podcast Episode 38
12 Jun 2020
Contributed by Lukas
This week on the pod we cover the latest COVID19 news, including antibody tests and their accuracy; A study aiming to examine treatments in children...
MPR Weekly Dose Podcast Episode 37
05 Jun 2020
Contributed by Lukas
This week on the pod we look at results from a COVID-19 prevention trial of hydroxychloroquine; A vaccine arrival date prediction by Dr Fauci; A FDA n...
MPR Weekly Dose Podcast Episode 36
29 May 2020
Contributed by Lukas
Today's pod covers important news regarding hydroxychloroquine; The efficacy of dietary supplements as a means to manage or prevent COVID-19; The firs...
MPR Weekly Dose Podcast Episode 35
22 May 2020
Contributed by Lukas
This week we cover the latest COVID-19 developments including: reports of false negatives with Abbott's diagnostic test; the immune globulin therapy l...
MPR Weekly Dose Podcast Episode 34
14 May 2020
Contributed by Lukas
This week we cover the latest COVID-19 developments including a triple antiviral therapy that looks promising, Emergency Use Authorizations granted to...
MPR Weekly Dose Podcast Episode 33
07 May 2020
Contributed by Lukas
This week we cover the the risk of antihypertensive med use during the pandemic; The Emergency Use Authorization for remdesivir in hospitalized patien...
MPR Weekly Dose Podcast Episode 32
30 Apr 2020
Contributed by Lukas
There has been a lot of recent developments in possible COVID-19 treatments. I'll go over the latest status with remdesivir, hydroxychloroquine, saril...
MPR Weekly Dose Podcast Episode 31
23 Apr 2020
Contributed by Lukas
On today's podcast we run through the top COVID-19 stories including a steep rise in poison control calls; the authorization of an at-home testing kit...
MPR Weekly Dose Podcast Episode 30
17 Apr 2020
Contributed by Lukas
We run through the latest COVID-19 news including results from a remdesivir trial; The blood purification system OK'd for patients in the ICU; A chlor...
MPR Weekly Dose Podcast Episode 29
09 Apr 2020
Contributed by Lukas
This week we run through the latest COVID-19 news including the shortage of critical meds, The CDC U-turn on face mask recommendations, Remdesivir tri...
MPR Weekly Dose Podcast Episode 28
03 Apr 2020
Contributed by Lukas
This episodes covers the latest COVID-19 news including drug shortages, a new point-of-care diagnostic tool, the role of vitamin C, misuse of non-phar...
MPR Weekly Dose Podcast Episode 27
27 Mar 2020
Contributed by Lukas
This week we talk about the latest on COVID-19, including the virus in relation to NSAID use; the pandemics knock on effect on drug shortages; a safet...
MPR Weekly Dose Podcast Episode 26
20 Mar 2020
Contributed by Lukas
This week we talk about a phase 1 vaccine trial for COVID-19 underway in Seattle; Concerns over COVID-19 and ACE inhibitor, ARB use; Safety labeling c...
MPR Weekly Dose Podcast Episode 25
12 Mar 2020
Contributed by Lukas
Today we talk about the latest COVID-19 news; New approvals for chronic fibrosing interstitial lung diseases and Cushing disease; and stronger safety ...
MPR Weekly Dose Podcast Episode 24
05 Mar 2020
Contributed by Lukas
Today we talk about the ban on certain electrical stimulation devices, the latest COVID-19 news, a first generic of Daraprim, a New Drug Application f...
MPR Weekly Dose Podcast Episode 23
27 Feb 2020
Contributed by Lukas
This week on the pod we cover a first-in-class cholesterol lowering therapy; a new indication for Trulicity; Macrolide prescriptions in the first trim...
MPR Weekly Dose Podcast Episode 22
20 Feb 2020
Contributed by Lukas
This week on the pod we cover the withdrawal of Belviq, the weight-loss drug, from the market; the over-the-counter approval of diclofenac gel and olo...
MPR Weekly Dose Podcast Episode 21
13 Feb 2020
Contributed by Lukas
This week on the pod we cover an insulin pump recall; Pharmacies running out of supplies in light of Covid-19 fears; Investigational Alzheimer disease...
MPR Weekly Dose Podcast Episode 20
06 Feb 2020
Contributed by Lukas
This week on the Pod we cover the approval of the first oral therapy for peanut allergy; The 2020 immunization schedule; The latest on the coronavirus...
MPR Weekly Dose Podcast Episode 19
30 Jan 2020
Contributed by Lukas
This week we discuss the latest news surrounding the novel coronavirus, including the WHO's decision to declare the virus a global emergency; A new tr...
MPR Weekly Dose Podcast Episode 18
24 Jan 2020
Contributed by Lukas
This week we cover the CDC coronavirus health advisory; A possible oral influenza vaccine; A new treatment to reduce the risk of MACE; An FDA Committe...
MPR Weekly Dose Podcast Episode 17
16 Jan 2020
Contributed by Lukas
This week we cover the approval of a cocaine nasal solution; 23andMe's entry into the drug development; The recall of an epilepsy and bipolar treatmen...
MPR Weekly Dose Podcast Episode 16
10 Jan 2020
Contributed by Lukas
In our first episode of 2020 we cover new management guidelines in osteoarthritis; Recommendations for the use of testosterone therapy; The best diets...
MPR Weekly Dose Podcast Episode 15
05 Dec 2019
Contributed by Lukas
Back from our Thanksgiving break, this week we talk about the new approval for sickle cell disease; the re-introduction of a product that was taken of...
MPR Weekly Dose Podcast: Episode 14
22 Nov 2019
Contributed by Lukas
MPR Weekly Dose Podcast: Episode 14 by MPR Weekly Dose
MPR Weekly Dose Podcast Episode 13
14 Nov 2019
Contributed by Lukas
This week on the Weekly Dose we talk about the first lung transplant due to vaping-related illness; A new approval for patients with beta thalassemia;...
MPR Weekly Dose Podcast Episode 12
08 Nov 2019
Contributed by Lukas
This week we talk about NDMA findings in ranitidine products; Approval of a new flu vaccine; The return of an antiarrhythmic agent; A new treatment fo...
MPR Weekly Dose Podcast: Episode 11
01 Nov 2019
Contributed by Lukas
This week we talk about the recall of an anti-anxiety med; Possible withdrawal of Makena; New MS treatment approved; IUD approved for up to six years;...
MPR Weekly Dose Podcast Episode 10
24 Oct 2019
Contributed by Lukas
This week we talk about the resurrection of Biogen's novel Alzheimer treatment; A "landmark" approval in cystic fibrosis; Expanded indication for Farx...
MPR Weekly Dose Podcast Episode 9
17 Oct 2019
Contributed by Lukas
This week we talk about new treatment approvals for acute migraine, dry eye disease and schizophrenia; a new indication for Xarelto; and the Centers f...
MPR Weekly Dose Podcast Episode 8
11 Oct 2019
Contributed by Lukas
This week we talk about the FDA highlighting THC in the recent spate of vaping-related illnesses; Descovy's expanded approval; A new cream for acne; A...
MPR Weekly Dose Podcast: Episode 7
04 Oct 2019
Contributed by Lukas
This week: New Invokana approval; More ranitidine recalls lead CVS to suspend all sales; FDA has identifies 11 serious cybersecurity vulnerabilities t...
MPR Weekly Dose Podcast: Episode 6
26 Sep 2019
Contributed by Lukas
This week: A new tablet treatment for type 2 diabetes; Pancreatitis treatment gains Orphan Drug status; New approval for smallpox, monkeypox; An inves...
MPR Weekly Dose Podcast: Episode 5
20 Sep 2019
Contributed by Lukas
This week: FDA votes on possible peanut allergy treatment; New risks ID'd with some breast cancer drugs; a topical solution for common warts edges nea...
MPR Weekly Dose Podcast: Episode 3
30 Aug 2019
Contributed by Lukas
This week: New adjunct treatment for Parkinson disease; Pain med associated with hypoglycemia; New approval for active ankylosing spondylitis; Fast tr...
MPR Weekly Dose Podcast: Episode 2
23 Aug 2019
Contributed by Lukas
This week: New draft guidelines for Lyme Disease management; First-in-class antibiotic to treat community-acquired bacterial pneumonia; Duchenne muscu...
MPR Weekly Dose Podcast: Episode 1
19 Aug 2019
Contributed by Lukas
This week the team discuss the 'Cure All' treatments that contain bleach, news concerning a Parkinson disease treatment, a new approval for a tubercul...